Cargando…
Immunological significance of alternative splicing prognostic signatures for bladder cancer
BACKGROUND: Bladder cancer (BLCA) is the most common malignant tumor in the genitourinary system, and the complex tumor microenvironment (TME) of BLCA is the main factor in its difficult treatment. Accumulated evidence supports that alternative splicing (AS) events frequently occur in cancer and are...
Autores principales: | Li, Xinyun, Yang, Lin, Huang, Wei, Jia, Bo, Lai, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873598/ https://www.ncbi.nlm.nih.gov/pubmed/35243106 http://dx.doi.org/10.1016/j.heliyon.2022.e08994 |
Ejemplares similares
-
Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021) -
Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021) -
Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022) -
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021) -
Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)